Letters: GPs could prescribe lower-cost medicines

On 14 September Eve Knight, of the British Cardiac Patients Association, wrote that guidance in a National Audit Office report on prescribing costs in primary care was 'financially driven' and 'independent of clinical or patient considerations'.

I would like to clarify what our report said. It does not recommend that GPs make clinical decisions based on cost. What it does say is that in some instances GPs could prescribe lower-cost clinically effective medicines, without affecting patient care. One example could be choosing genericover branded drugs where the clinical outcome is proven to be the same.

By doing this PCTs could save more than £200 million a year. As parliament's public spending watchdog, we believe that such sums are worth saving and ploughing back into patient care. But patient care should always remain the primary concern.

Julian Wood, Director of marketing and communications, National Audit Office.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in


Just published

Person selecting medicine in a dispensary

Dispensing GPs demand funding overhaul to ensure services remain viable

Dispensing doctors have demanded improved representation in GP contract negotiations,...

GP consultation room

GPs seeing cases of malnutrition and rickets as cost-of-living crisis hits patient health

Three quarters of GPs are seeing a rise in patients with problems linked to the cost-of-living...

Female GP listening to a patient

What GPs need to know about changes to Good Medical Practice

Dr Udvitha Nandasoma, the MDU’s head of advisory services, explains what GPs need...

Dr Caroline Fryar

Viewpoint: Doctors should be given protected time to digest Good Medical Practice

There's a lot for doctors to digest in the GMC's Good Medical Practice update before...

MIMS Learning Clinical Update podcast

MIMS Learning Clinical Update podcast explores the ‘defining issue of our age’

The latest episode of the MIMS Learning Clinical Update podcast features an interview...

Statin

NICE moves CVD advice closer to QOF and updates treatment escalation options

NICE draft guidance on cardiovascular disease backs a new target for lipid levels...